Prognosis
Prognosis
The overall prognosis is good. Although response to treatment typically occurs within 24 to 72 hours, relapses or symptom exacerbations are common. Treatment is typically required for 2 to 3 years. Less commonly, there is a chronic relapsing course that may require a longer course of treatment. PMR may also be associated with giant cell arteritis (GCA) and if present, the prognosis and treatment is directly related to GCA.[60][61]
Increased risk of relapse or prolonged therapy has shown association with female sex, high ESR (>40 mm/hour), and peripheral arthritis at diagnosis.[48]
Use of this content is subject to our disclaimer